<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Biotherapy</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Biotherapy</journal-title><trans-title-group xml:lang="ru"><trans-title>Российский биотерапевтический журнал</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1726-9784</issn><issn publication-format="electronic">1726-9792</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">875</article-id><article-id pub-id-type="doi">10.17650/1726-9784-2017-16-3-21-23</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>REVIEWS</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОБЗОРЫ ЛИТЕРАТУРЫ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Role of tumor-like multipotent mesenchymal stromal cells in rheumatoid arthritis</article-title><trans-title-group xml:lang="ru"><trans-title>Роль опухолеподобных мезенхимальных мультипотентных клеток при ревматоидном артрите</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kiselevskiy</surname><given-names>M. V.</given-names></name><name xml:lang="ru"><surname>Киселевский</surname><given-names>М. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Anisimova</surname><given-names>N. Yu.</given-names></name><name xml:lang="ru"><surname>Анисимова</surname><given-names>Н. Ю.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Chikileva</surname><given-names>I. O.</given-names></name><name xml:lang="ru"><surname>Чикилева</surname><given-names>И. О.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Vlasenko</surname><given-names>R. Ya.</given-names></name><name xml:lang="ru"><surname>Власенко</surname><given-names>Р. Я.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Dolzhikova</surname><given-names>Yu. I.</given-names></name><name xml:lang="ru"><surname>Должикова</surname><given-names>Ю. И.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Sitdikova</surname><given-names>S. M.</given-names></name><name xml:lang="ru"><surname>Ситдикова</surname><given-names>С. М.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>suriyasitdikova@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Senatov</surname><given-names>F. S.</given-names></name><name xml:lang="ru"><surname>Сенатов</surname><given-names>Ф. С.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Yang</surname><given-names>K. C.</given-names></name><name xml:lang="ru"><surname>Янг</surname><given-names>К. С.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Yang</surname><given-names>J. C.</given-names></name><name xml:lang="ru"><surname>Янг</surname><given-names>Д. С.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff4"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">N.N. Blokhin Russian Cancer Research Center</institution></aff><aff><institution xml:lang="ru">ФГБУ«НМИЦ онкологии им. Н.Н. Блохина» Минздрава России</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">National University of Science and Technology“MISIS”</institution></aff><aff><institution xml:lang="ru">НИТУ«МИСиС»</institution></aff></aff-alternatives><aff id="aff3"><institution>School of Dental Technology, College of Oral Medicine</institution></aff><aff id="aff4"><institution>Graduate Institute of Nanomedicine and Medical Engineering College of Biomedical Engineering, Taipei Medical University</institution></aff><pub-date date-type="pub" iso-8601-date="2017-09-30" publication-format="electronic"><day>30</day><month>09</month><year>2017</year></pub-date><volume>16</volume><issue>3</issue><fpage>21</fpage><lpage>23</lpage><history><date date-type="received" iso-8601-date="2018-04-10"><day>10</day><month>04</month><year>2018</year></date></history><permissions/><self-uri xlink:href="https://bioterapevt.abvpress.ru/jour/article/view/875">https://bioterapevt.abvpress.ru/jour/article/view/875</self-uri><abstract xml:lang="en"><p>Multipotent mesenchymal stromal/stem cells (MSCs) are regarded as a stable, safe and easily available source of precursor cells for purposes of regenerative medicine. However, under repeated replication in tissue reparation processes and action of inflammatory mediators, aged MSCs may be transformed and obtain certain tumor-cell characteristics. The present review deals with the MSCs role in pathogenesis of rheumatoid arthritis. High proliferation speed, lack of contact inhibition and invasive growth of transformed MSCs is an important mechanism of cartilage destruction in rheumatoid arthritis.</p></abstract><trans-abstract xml:lang="ru"><p>Мезенхимальные стволовые (мультипотентные) клетки (МСК) считаются стабильным, безопасным и доступным источником клеток-предшественников для целей регенеративной медицины. Однако МСК не только могут участвовать в процессах репарации тканей, но b при воздействии триггеров и медиаторов воспаления способны к трансформации, приобретая при этом свойства опухолевых клеток. Настоящий обзор посвящен роли МСК в патогенезе ревматоидного артрита. Высокая скорость пролиферации, отсутствие контактного торможения и инвазионный рост трансформированных МСК является важным механизмом деструкции хряща при ревматоидном артрите.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>мультипотентные стволовые клетки</kwd><kwd>ревматоидный артрит</kwd><kwd>деструкция</kwd><kwd>хрящ</kwd><kwd>mesenchymal stem cells</kwd><kwd>rheumatoid arthritis</kwd><kwd>destruction</kwd><kwd>cartilage</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Horwitz E.M., Le Blanc K., Dominici M. et al. International Society for Cellular Therapy. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy 2005;7:393-5. DOI: 10.1080/14653240500319234.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Ullah I., Subbarao R.B., Rho G.J. Human mesenchymal stem cells -current trendsand future prospective. Biosci Rep 2015/35/art:e00191. DOI: 10.1042/BSR20150025.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Wakitani S., Saito T., Caplan A.I. Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve 1995;18: 1417-26. DOI: 10.1002/mus.880181212.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Xu W., Zhang X., Qian H. et al. Mesenchymal stem cells from adult human bone marrow differentiate into a cardiomyocyte phenotype in vitro. Exp Biol Med 2004;229:623-31.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Tang D.Q., Wang Q., Burkhardt B.R. et al. In vitro generation of functional insulin-producing cells from human bone marrow-derived stem cells, but longterm culture running risk of malignant transformation. Am J Stem Cells 2012;1:114-27.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Gabr M.M., Zakaria M.M., Refaie A.F. et al. Insulin-producing cells from adult human bone marrow mesenchymal stem cells control streptozotocin-induced diabetes in nude mice. Cell Transplant 2013;22:133-45. DOI: 10.3727/096368912X647162.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Rengasamy M., Gupta P.K., Kolkundkar U. et al. Preclinical safety &amp; toxicity evaluation of pooled, allogeneic human bone marrow-derived mesenchymal stromal cellsIndian. J Med Res 2016;6:852-</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>DOI: 10.4103/ijmr. IJMR_1842_15.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Firestein G.S. Evolving concepts of rheumatoid arthritis. Nature 2003;423:356-61. DOI: 10.1038/nature01661.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Pap T., Muller-Ladner U., Gay R.E., Gay S. Fibroblast biology. Role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis. Arthritis Res 2000;2:361-7. DOI: 10.1186/ar113.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Edwards J.C. Fibroblast biology. Development and differentiation of synovial fibroblasts in arthritis. Arthritis Res 2000;2:344-47. DOI: 10.1186/ar110.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Firestein G.S. Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Passive responders or transformed aggressors? Arthritis Rheum 1996;39:1781-90. DOI: 10.1002/art.1780391103.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Muller-Ladner U., Kriegsmann J., Gay R.E., Gay S. Oncogenes in rheuma toid arthritis. Rheum Dis Clin North Am 1995;21:675-90.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Lafyatis R., Remmers E.F., Roberts A.B. et al. Anchorage-independent growth of synoviocytes from arthritic and normal joints. Stimulation by exogenous platelet-derived growth factor and inhibition by transforming growth factor-beta and retinoids. J Clin Invest 1989;83:1267-76.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Yamasaki S., Nakashima T., Kawakami A. et al. Cytokines regulate fibroblast-like synovial cell differentiation to adipocytelike cells. Rheumatology (Oxford) 2004;43:448-52.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Li X., Makarov S.S. An essential role of NF-B in the tumor-like phenotype of arthritic synoviocytes. PNAS 2006;103 (46):17437. DOI: 10.1007/s10753-015-0220-3.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Geiler T., Kriegsmann J., Keyszer G.M. et al. A new model for rheumatoid arthritis generated by engraftment of rheumatoid synovial tissue and normal human cartilage into SCID mice. Arthritis Rheum 1994;37:1664-71.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Müller-Ladner U., Kriegsmann J., Franklin B.N. et al. Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Am J Pathol 1996;49:1607-15.</mixed-citation></ref></ref-list></back></article>
